| Research Article Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study |  Felicia Montero-Arias MD, Jose Carlos Herrera Garcia MD, Manuel Pacheco Gallego MD, MHA, MSc, Martti Anton Antila MD, Patricia Schonffeldt MD, Walter Javier Mattarucco MD, Luis Fernando Tejado Gallegos MD, MPH, MHA & Maarten J. H. I. Beekman MD Pages: 1-14 | DOI: 10.1080/02770903.2022.2082305 Evaluation of the factors affecting lung function in pediatric patients with asthma Tao Ai MB, Ying Wu MB, Lei Zhang MM, Ronghua Luo MB, Huling Liao MB, Yinghong Fan MB, Wanmin Xia MB, Cheng Xie MB & Libing Zhang MD Pages: 1-9 | DOI: 10.1080/02770903.2022.2087670 Development and assessment of a low literacy, pictographic asthma action plan with clinical automation to enhance guideline-concordant care for children with asthma Patrick T. Reeves MD, Timothy M. Kenny DO, Laura T. Mulreany MD, Michael Y. McCown MD, Jane E. Jacknewitz-Woolard RN, DNP, CS, P/FNP, Philip L. Rogers MD, Sofia Echelmeyer BFA & Sebastian K. Welsh MD Pages: 1-18 | DOI: 10.1080/02770903.2022.2087188 One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study | Masaharu Shinkai MD, PhD, Motohiro Ebisawa MD, PhD, Yasushi Fukushima MD, PhD, Satomi Takeuchi MD, Hiroshi Okada MD, Tatsuro Tokiyo MS, Nobuya Hayashi MS, Mami Takikawa MS, Gene Colice MD & Gun Almqvist MS Pages: 1-9 | DOI: 10.1080/02770903.2022.2082309 Review Barriers and facilitators of electronic patient portal uptake for asthma management Ilana Radparvar BA & Mindy K. Ross MD, MBA, MAS Pages: 1-12 | DOI: 10.1080/02770903.2022.2087190 |